Home » Topics » Regulatory

Regulatory
RSS

Novartis receives first approval for Gilenya MS therapy in Russia

Sep. 10, 2010

E.U. approves Brinavess for rapid conversion of recent-onset AF

Sep. 3, 2010

FDA approves Novartis' Tekamlo for hypertension

Aug. 27, 2010

Takepron approved for additional indication in Japan

Aug. 24, 2010

Precedex IV 200 mcg approved for long-term use in Japan

Aug. 23, 2010

FDA approves new docetaxel injection concentrate formulation for cancer

Aug. 6, 2010

FDA accepts NDA for gadobutrol injection in MRI of CNS

Aug. 6, 2010

FDA approves two new dose strengths of niacin/simvastatin

July 29, 2010

FDA approves Cuvposa for chronic drooling in children with neurological disorders

July 29, 2010

FDA approves Daiichi Sankyo's Tribenzor for hypertension

July 27, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...